Synopsis: There was a time when if you were a tech company and you didn’t have an office in Bengaluru, then you were not really a tech company. The VCs would not even give you money. Pharma has become like that, too. If you look at big pharma, big funds, VC funds in the US, private equity funds in the US—they all have offices and full-fledged staff sitting in China doing things. They’re following new cohorts of assets that they got from China. China will definitely, going forward, be very important in everybody’s plans.

India today stands on the brink of its biggest chronic health wave – obesity. Nearly 300 million Indians are now within the risk spectrum, marking a surge that didn’t exist two decades ago.

At the same time, a new class of powerful drugs — GLP-1 analogues — is redefining

See Full Page